HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rui Wan Selected Research

Simazine

2/2014Simazine biodegradation and community structures of ammonia-oxidizing microorganisms in bioaugmented soil: impact of ammonia and nitrate nitrogen sources.
1/2014Simazine degradation in bioaugmented soil: urea impact and response of ammonia-oxidizing bacteria and other soil bacterial communities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rui Wan Research Topics

Disease

11Neoplasms (Cancer)
01/2021 - 01/2017
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 01/2017
3Lung Neoplasms (Lung Cancer)
01/2021 - 08/2017
2Disease Progression
01/2021 - 10/2020
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 01/2019
2Neoplasm Metastasis (Metastasis)
01/2020 - 08/2017
2Adenocarcinoma of Lung
01/2019 - 01/2018
2Type I Syndactyly
02/2014 - 01/2014
1Morbid Obesity
06/2022
1Tertiary Lymphoid Structures
10/2020
1Carcinoma (Carcinomatosis)
10/2020
1Exanthema (Rash)
10/2020
1Angiomyolipoma
01/2020
1Fatigue
01/2019
1Hypertension (High Blood Pressure)
01/2019
1Hand-Foot Syndrome
01/2019
1Microsatellite Instability
11/2018
1Stomach Neoplasms (Stomach Cancer)
01/2017
1Nevus (Nevi)
12/2014

Drug/Important Bio-Agent (IBA)

4LigandsIBA
01/2021 - 11/2018
4Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2018
2PlatinumIBA
01/2021 - 01/2019
2Complementarity Determining Regions (Complementarity Determining Region)IBA
01/2021 - 01/2020
2Immune Checkpoint InhibitorsIBA
12/2020 - 11/2018
2SimazineIBA
02/2014 - 01/2014
1DNA (Deoxyribonucleic Acid)IBA
10/2022
1Melanocortin Receptors (Melanocortin Receptor)IBA
06/2022
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
06/2022
1Bevacizumab (Avastin)FDA Link
12/2021
1Capsules (Microcapsules)IBA
01/2021
1Etoposide (VP 16)FDA LinkGeneric
01/2021
1Phosphotransferases (Kinase)IBA
12/2020
1EphrinsIBA
12/2020
1tyrosine receptor (receptor, tyrosine)IBA
12/2020
1AntibodiesIBA
10/2020
1AmylasesFDA Link
10/2020
1toripalimabIBA
10/2020
1Monoclonal AntibodiesIBA
10/2020
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2020
1EverolimusFDA Link
01/2020
1B7-H1 AntigenIBA
01/2020
1Programmed Cell Death 1 ReceptorIBA
01/2020
1TransglutaminasesIBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1apatinibIBA
01/2019
1Docetaxel (Taxotere)FDA Link
01/2019
1Alanine Transaminase (SGPT)IBA
01/2019
1BilirubinIBA
01/2019
1Death Domain ReceptorsIBA
11/2018
1Immunoglobulins (Immunoglobulin)IBA
01/2017
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1Cysteine (L-Cysteine)FDA Link
01/2017
1Circulating Tumor DNAIBA
01/2017
1Albumin-Bound PaclitaxelFDA Link
01/2017
1130-nm albumin-bound paclitaxelIBA
01/2017
1HLA-G Antigens (HLA G)IBA
01/2017
1Keratin-13 (Keratin 13)IBA
12/2014
1NitrogenIBA
02/2014
1NitratesIBA
02/2014
1AmmoniaIBA
02/2014
1TriazinesIBA
01/2014
1FertilizersIBA
01/2014
1HerbicidesIBA
01/2014
1Urea (Carbamide)FDA LinkGeneric
01/2014

Therapy/Procedure

9Therapeutics
10/2022 - 01/2017
6Drug Therapy (Chemotherapy)
01/2021 - 08/2017
4Immunotherapy
01/2021 - 01/2020
1Adjuvant Chemotherapy
01/2021